Skip to main content
. Author manuscript; available in PMC: 2020 Dec 29.
Published in final edited form as: Am J Clin Oncol. 2019 Oct;42(10):744–748. doi: 10.1097/COC.0000000000000590

Table 2.

Univariate Analyses for distant metastatic free survival, disease specific survival and local control

Variable DMFS at 5y DMFS P value DSS at 10y DSS P Value LC at 10y LC P Value
Sex
 Female 78 0.67 100 0.67 100 0.73
 Male 80 80 87
Age, years
 ≤ 65 66 0.43 87 0.57 89 0.70
 >65 86 75 100
Tumor Location
 Head and neck 100 0.48 100 0.96 100 0.35
 Trunk 50 100 100
 Upper Extremities 88 80 100
 Lower Extremities 70 80 82
Tumor Size
 > 5 cm 59 0.02 80 0.15 87 0.60
 ≤ 5 cm 100 100 100
Final Margin Status
 Positive/Uncertain 67 0.25 83 0.91 80 0.12
 Negative 70 86 93
Treatment Plan
 Surgery alone 75 0.55 100 0.42 63 0.01
 Postoperative RT 50 76 100
 Preoperative RT 76 83 100
Combined local therapy
 Yes 67 0.91 80 0.19 100 0.004
 No 75 100 63
Chemotherapy
 Neo or adjuvant 67 0.53 100 0.39 67 0.32
 None 69 83 94

Abbreviations: DMFS, distant metastatic free survival; DSS, disease specific survival; OS, overall survival; RT, radiation therapy